Viviane D. Lima

Suboptimal use of HIV drug resistance testing in a universal health-care setting

Kimberly A. Fernandes, R. Hogg, R. Harrigan, 2011, AIDS care.

Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.

P. Harrigan, B. Yip, R. Hogg, 2008, The Journal of infectious diseases.

Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996-2016.

P. Harrigan, J. Shoveller, C. Brumme, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Suboptimal use of HIV drug resistance testing in a universal health-care setting

Kimberly A. Fernandes, A. Palmer, E. K. Brandson, 2011, AIDS Care.

Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada

W. Honer, J. Montaner, A. Thornton, 2020, PLoS medicine.

Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAART

P. Harrigan, B. Yip, R. Hogg, 2006, PLoS medicine.

Emergent drug resistance with integrase strand transfer inhibitor-based regimens

P. Harrigan, B. Yip, J. Montaner, 2017, AIDS.